These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2413663)

  • 21. [Reactivity of neutrophils in systems with peptidoglycans of different species of Staphylococcus].
    Lebedeva IuV; Astaf'ev DG; Maianskiĭ AN
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):57-61. PubMed ID: 2800794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological specificity of natural opsonins and their role in the cross-reactivity between Staphylococcus aureus Mardi and Escherichia coli 101.
    Young DA; Dobson P; Karakawa WW
    Infect Immun; 1979 Sep; 25(3):954-9. PubMed ID: 91583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differing complement-mediated opsonic activity of rabbit interstitial fluids from autologous serum.
    Lam C; Georgopoulos A; Schütze E
    Comp Immunol Microbiol Infect Dis; 1988; 11(1):1-9. PubMed ID: 3289826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the opsonic activity of purified bovine sIgA following intramammary immunization of cows with Staphylococcus aureus.
    Barrio MB; Rainard P; Gilbert FB; Poutrel B
    J Dairy Sci; 2003 Sep; 86(9):2884-94. PubMed ID: 14507024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in specific opsonic activity in bovine milk following experimental Escherichia coli mastitis.
    Hill AW; Heneghan DJ; Field TR; Williams MR
    Res Vet Sci; 1983 Sep; 35(2):222-6. PubMed ID: 6356257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The characteristics of Staphylococcus aureus peptidoglycan in the spectrum of the reactivity of human lymphocytes to bacterial peptidoglycans].
    Osipov OA; Sibiriakova NI; Astaf'ev DG; Rassanov SP; Maianskiĭ AN
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Sep; (9):60-2. PubMed ID: 1759526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunochemical study of the peptidoglycan of gram-negative bacteria.
    Nguyen-Huy H; Nauciel C; Wermuth CG
    Eur J Biochem; 1976 Jun; 66(1):79-84. PubMed ID: 60233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface phagocytosis of Staphylococcus epidermidis and Escherichia coli by human neutrophils: serum requirements for opsonization and chemiluminescence.
    Gordon DL; Avery VM; Rice JL; McDonald PJ
    FEMS Microbiol Immunol; 1989 Dec; 1(8-9):417-23. PubMed ID: 2697319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of high and low pressure on phagocytosis of Escherichia coli by human neutrophils in vitro.
    Lingaas E; Midtvedt T
    Aviat Space Environ Med; 1987 Dec; 58(12):1211-4. PubMed ID: 3322252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opsonin effect of F(ab')2 fragment of human immunoglobulin on bacterial phagocytosis by human neutrophils.
    Yamada Y; Kimura S; Azuma T; Umezawa Y; Sendo F
    Microbiol Immunol; 1986; 30(2):187-91. PubMed ID: 3520248
    [No Abstract]   [Full Text] [Related]  

  • 31. Opsonin-dependent and independent surface phagocytosis of S. aureus proceeds independently of complement and complement receptors.
    Gordon DL; Rice JL
    Immunology; 1988 Aug; 64(4):709-14. PubMed ID: 2971611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial properties of breast milk: requirements for surface phagocytosis and chemiluminescence.
    Avery VM; Gordon DL
    Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1034-9. PubMed ID: 1802694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective and opsonic activities of a native, pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens.
    Hill HR; Bathras JM
    Rev Infect Dis; 1986; 8 Suppl 4():S396-400. PubMed ID: 3092306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opsonic activity of bovine serum and mammary secretion after Escherichia coli J5 vaccination.
    Hogan JS; Todhunter DA; Tomita GM; Smith KL; Schoenberger PS
    J Dairy Sci; 1992 Jan; 75(1):72-7. PubMed ID: 1541744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opsonic activity of immunoglobulin prepared for intravenous use.
    Hetherington SV; Giebink GS
    J Lab Clin Med; 1984 Dec; 104(6):977-86. PubMed ID: 6502004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opsonic activity in human serum deficient in C2.
    Johnson FR; Agnello V; Williams RC
    J Immunol; 1972 Jul; 109(1):141-5. PubMed ID: 4402482
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunologic regulation of E. coli K1 by serum from neonatal rats is enhanced following intraperitoneal administration of human IgG.
    Lassiter HA; Christensen RD; Parker CJ
    J Infect Dis; 1989 Mar; 159(3):518-25. PubMed ID: 2644382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opsonic defense to Staphylococcus epidermidis in the premature neonate.
    Fleer A; Gerards LJ; Aerts P; Westerdaal NA; Senders RC; van Dijk H; Verhoef J
    J Infect Dis; 1985 Nov; 152(5):930-7. PubMed ID: 4045255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonococcal protein I-specific opsonic IgG in normal human serum.
    Sarafian SK; Tam MR; Morse SA
    J Infect Dis; 1983 Dec; 148(6):1025-32. PubMed ID: 6197495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative opsonic and protective activities of antibodies against K1, O and lipid A antigens of Escherichia coli.
    Welch WD; Martin WJ; Stevens P; Young LS
    Scand J Infect Dis; 1979; 11(4):291-301. PubMed ID: 93778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.